• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

紫杉醇与人血清白蛋白的高亲和力结合。

High affinity binding of paclitaxel to human serum albumin.

作者信息

Paál K, Müller J, Hegedûs L

机构信息

Department of Pharmaceutical Research and Development, HUMAN Co. Ltd, Gödöllõ, Hungary.

出版信息

Eur J Biochem. 2001 Apr;268(7):2187-91. doi: 10.1046/j.1432-1327.2001.02107.x.

DOI:10.1046/j.1432-1327.2001.02107.x
PMID:11277943
Abstract

Paclitaxel, a very potent antitumor agent is a hydrophobic molecule with low aqueous solubility. Its currently used formula (Taxol) contains the drug in a 1 : 1 (v/v) mixture of ethanol and Cremophor EL. To minimize vehicle-related toxicity, we developed a novel, water-soluble formulation in which paclitaxel is bound noncovalently to human serum albumin. For this purpose, studies of the paclitaxel-albumin binding equilibrium were performed. Paclitaxel dissolved in ethanol was added to the aqueous solution of human serum albumin. Precipitated paclitaxel was removed and unbound drug was separated by ultrafiltration. Paclitaxel concentration was measured by RP-HPLC. Binding data were evaluated based both on the Scatchard plot and the general binding equation describing binding equilibria with the stepwise stoichiometric binding constants. The Scatchard plot was found to be curvilinear with a slight positive slope of the final part. Parameters of high affinity specific binding were determined from the initial part of the curve (nsp = 1.3 and Ksp = 1.7 x 10(6) M(-1)). Stoichiometric binding constants were estimated by fitting the general binding equation to the experimental data (K1 = 2.4 x 10(6) M(-1) and K2 = 1.0 x 10(5) M(-1)). Saturation of the protein with paclitaxel, similarly to other ligands of albumin, could not be reached. The greatest observed value of r (number of paclitaxel molecules bound to one albumin molecule) was 6.6.

摘要

紫杉醇是一种非常有效的抗肿瘤药物,是一种疏水性分子,水溶性低。其目前使用的配方(泰素)中药物以乙醇和聚氧乙烯蓖麻油EL按1:1(v/v)的混合物形式存在。为了将与载体相关的毒性降至最低,我们开发了一种新型的水溶性制剂,其中紫杉醇与人类血清白蛋白非共价结合。为此,进行了紫杉醇-白蛋白结合平衡的研究。将溶解在乙醇中的紫杉醇加入到人类血清白蛋白的水溶液中。去除沉淀的紫杉醇,通过超滤分离未结合的药物。通过反相高效液相色谱法测定紫杉醇浓度。基于Scatchard图和描述具有逐步化学计量结合常数的结合平衡的一般结合方程对结合数据进行评估。发现Scatchard图呈曲线状,最后部分有轻微的正斜率。从曲线的初始部分确定高亲和力特异性结合的参数(nsp = 1.3,Ksp = 1.7×10⁶ M⁻¹)。通过将一般结合方程拟合到实验数据来估计化学计量结合常数(K1 = 2.4×10⁶ M⁻¹,K2 = 1.0×10⁵ M⁻¹)。与白蛋白的其他配体类似,无法使蛋白质被紫杉醇饱和。观察到的最大r值(与一个白蛋白分子结合的紫杉醇分子数)为6.6。

相似文献

1
High affinity binding of paclitaxel to human serum albumin.紫杉醇与人血清白蛋白的高亲和力结合。
Eur J Biochem. 2001 Apr;268(7):2187-91. doi: 10.1046/j.1432-1327.2001.02107.x.
2
Palmitate and stearate binding to human serum albumin. Determination of relative binding constants.
J Pept Res. 1997 Apr;49(4):347-54. doi: 10.1111/j.1399-3011.1997.tb01136.x.
3
Nonlinear pharmacokinetics of paclitaxel in mice results from the pharmaceutical vehicle Cremophor EL.紫杉醇在小鼠体内的非线性药代动力学是由药用辅料聚氧乙烯蓖麻油引起的。
Cancer Res. 1996 May 1;56(9):2112-5.
4
The binding of thiopental to serum proteins determined by ultrafiltration and equilibrium dialysis.通过超滤和平衡透析法测定硫喷妥与血清蛋白的结合。
Acta Pharmacol Toxicol (Copenh). 1980 Jul;47(1):24-32. doi: 10.1111/j.1600-0773.1980.tb02020.x.
5
Development and validation of a method to determine the unbound paclitaxel fraction in human plasma.一种测定人血浆中游离紫杉醇分数方法的开发与验证
Anal Biochem. 2004 Jan 1;324(1):11-5. doi: 10.1016/j.ab.2003.07.024.
6
Liposome formulation of paclitaxel with enhanced solubility and stability.具有增强溶解性和稳定性的紫杉醇脂质体制剂。
Drug Deliv. 2007 Jul;14(5):301-8. doi: 10.1080/10717540601098799.
7
A two-constant equation for multiple albumin-binding isotherms.用于多个白蛋白结合等温线的双常数方程。
J Pharm Sci. 1986 Jul;75(7):669-71. doi: 10.1002/jps.2600750710.
8
Measurement of fraction unbound paclitaxel in human plasma.人血浆中游离紫杉醇分数的测定。
Drug Metab Dispos. 2000 Oct;28(10):1141-5.
9
Effect of unpurified Cremophor EL on the solution stability of paclitaxel.未纯化的聚氧乙烯蓖麻油(Cremophor EL)对紫杉醇溶液稳定性的影响。
Pharm Dev Technol. 2009;14(1):1-8. doi: 10.1080/10837450802409354.
10
Folate-mediated targeting of albumin conjugates of paclitaxel obtained through a heterogeneous phase system.通过多相体系获得的叶酸介导的白蛋白结合紫杉醇缀合物的靶向作用。
Int J Pharm. 2009 Dec 1;382(1-2):117-23. doi: 10.1016/j.ijpharm.2009.08.018. Epub 2009 Aug 25.

引用本文的文献

1
"Nano-Paclitaxel" Unlocking Potential and Redefining Cancer Chemotherapy.“纳米紫杉醇”:释放潜能,重新定义癌症化疗
ACS Omega. 2025 Jun 27;10(27):28670-28690. doi: 10.1021/acsomega.5c02916. eCollection 2025 Jul 15.
2
Glycocalyx Interactions Modulate the Cellular Uptake of Albumin-Coated Nanoparticles.糖萼相互作用调节白蛋白包覆的纳米颗粒的细胞摄取。
ACS Appl Bio Mater. 2024 Nov 18;7(11):7365-7377. doi: 10.1021/acsabm.4c01012. Epub 2024 Oct 29.
3
Advancing Tumor Therapy: Development and Utilization of Protein-Based Nanoparticles.
推进肿瘤治疗:基于蛋白质的纳米颗粒的开发与应用
Pharmaceutics. 2024 Jul 1;16(7):887. doi: 10.3390/pharmaceutics16070887.
4
"Abraxane-Like" Radiosensitizer for In Situ Oral Cancer Therapy.用于原位口腔癌治疗的“Abraxane 样”增敏剂。
Adv Sci (Weinh). 2024 Sep;11(34):e2309569. doi: 10.1002/advs.202309569. Epub 2024 Jul 7.
5
Neutrophil-Mediated Delivery of Nanocrystal Drugs via Photoinduced Inflammation Enhances Cancer Therapy.中性粒细胞介导的光诱导炎症纳米晶药物递送增强癌症治疗。
ACS Nano. 2023 Aug 22;17(16):15542-15555. doi: 10.1021/acsnano.3c02013. Epub 2023 Aug 14.
6
Albumin-Bound Paclitaxel: Worthy of Further Study in Sarcomas.白蛋白结合型紫杉醇:值得在肉瘤中进一步研究。
Front Oncol. 2022 Feb 10;12:815900. doi: 10.3389/fonc.2022.815900. eCollection 2022.
7
Paclitaxel Drug Delivery Systems: Focus on Nanocrystals' Surface Modifications.紫杉醇药物递送系统:聚焦于纳米晶体的表面修饰
Polymers (Basel). 2022 Feb 9;14(4):658. doi: 10.3390/polym14040658.
8
Protein nanoparticles directed cancer imaging and therapy.蛋白质纳米颗粒用于癌症成像与治疗。
Nano Converg. 2022 Jan 8;9(1):2. doi: 10.1186/s40580-021-00293-4.
9
Bioequivalence assessment of high-capacity polymeric micelle nanoformulation of paclitaxel and Abraxane® in rodent and non-human primate models using a stable isotope tracer assay.使用稳定同位素示踪分析评估紫杉醇高载药聚合物胶束纳米制剂及 Abraxane® 在啮齿类动物和非人类灵长类动物模型中的生物等效性。
Biomaterials. 2021 Nov;278:121140. doi: 10.1016/j.biomaterials.2021.121140. Epub 2021 Oct 2.
10
Boron rich nanotube drug carrier system is suited for boron neutron capture therapy.富硼纳米管药物载体系统适合硼中子俘获疗法。
Sci Rep. 2021 Jul 30;11(1):15520. doi: 10.1038/s41598-021-95044-0.